• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2000 Fiscal Year Final Research Report Summary

GENETIC POLYMORPHISM OF DRUG METABOLIZING-ENZYME ; ANALYSIS OF NOVEL POLYMORPHISM AND DEVELOPMENT OF GENOTYPING METHOD

Research Project

Project/Area Number 10557242
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field 応用薬理学・医療系薬学
Research InstitutionHOKKAIDO UNIVERSITY

Principal Investigator

ARIYOSHI Noritaka  Hokkaido Univ., Asso.Prof., 大学院・薬学研究科, 助教授 (00243957)

Co-Investigator(Kenkyū-buntansha) NAKAYAMA Kazuo  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (20261323)
TAKAHASHI Yoshiki  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (80292019)
FUJITA Ken-ichi  Hokkaido Univ., Inst., 大学院・薬学研究科, 助手 (60281820)
MINE Tsuyoshi  Sumitomo Pharm., Senior Investigator, 主任研究員
KAMATAKI Tetsuya  Hokkaido Univ., Prof., 大学院・薬学研究科, 教授 (00009177)
Project Period (FY) 1998 – 2000
Keywordsdrug metabolism / cytochrome P450 / genetic polymorphism / CYP2D6 / Adverse reaction / poor metabolizer / gene analysis / CYP2D6^*36
Research Abstract

CYP2D6 is a form of cytochrome P450(CYP)involved in the metabolism of more than 40 clinically important drugs including some tricyclic antidepressants, antiarrhythmics, b-adrenergic blockers and histamin H_1 antagonists. This form of CYP is polymorphically expressed in a population and characterized as two phenotypes, extensive metabolizers and poor metabolizers(PM). It was assumed that there may be some unknown polymorphisms in Orientals, because major variants in Caucasians could not fully account for the frequency of the PM in Japanese. Analysis of the CYP2D6 gene in two Japanese PMs identified by phenotyping using debrisoquine was performed. As a result, novel two mutations were discovered. was one-base insertion in exon 5, leading to generation a stop codon at 11 dp downstream. This variant was designated as the CYP2D6^*21. The other one was tandem repeat of inactive gene, CYP2D6^*36, at regions of the CYP2D locus. Genotyping method was established against each of the variant allele. The frequency of the CYP2D6^*36-^*36 could not be determined in this study due to small sise of subjects. On the other hand, the CYP2D6^*21 appeared to be one of the major variant causing PM phenotype in Japanese.

  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Michihiro Chida et al.: "Analysis of short fragment amplified by LA-PCR for diagnosis of CYP2D6*5"Japanese Journal of Clinical Pharmacology and Therapeutics. 31. 433-434 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Michihiro Chida et al.: "A new variant CYP2D6 allele (CYP2D6*21) with a single base insertion in exon 5 in a Japanese population associated with a poor metabolizer phenotype"Pharmacogenetics. 9. 287-293 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Michihiro Chida et al.: "Genetic polymorphism of CYP2D6 in Japanese population"Pharmacogenetics. 9. 601-609 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Tomonori Tateishi et al.: "Analysis of the CYP2D6 gene in relation to dextromethorphan O-demethylation capacity in a Japanese population"Clinical Pharmacology and Therapeutics. 65. 570-575 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Michihiro Chida et al.: "Relationship between genotype and phenotype of CYP2D6 in Japanese"Japanese Journal of Clinical Pharmacology and Therapeutics. 30. 81-82 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Michihiro Chida et al.: "Discovery of a new variant CYP2D6 allele (CYP2D6/Ch2-Ch2) in Japanese population"Japanese Journal of Clinical Pharmacology and Therapeutics. 29. 239-240 (1998)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 有吉範高: "月刊薬事3月臨時増刊号"じほう. 834 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 有吉範高: "薬物代謝学"東京化学同人. 282 (2000)

    • Description
      「研究成果報告書概要(和文)」より

URL: 

Published: 2002-03-26  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi